(Q45227635)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362506%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

Prevalence of elevated liver enzymes in Type 2 diabetes mellitus and its association with the metabolic syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362506%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362506%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Procolo Di Bonito

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362506%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Luca Scaldaferri

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362506%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Giulio Marchesini

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362506%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

G Forlani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362506%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

E Mannucci

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362506%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

B Capaldo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362506%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

S Genovese

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362506%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

M Orrasch

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362506%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

P Di Bartolo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362506%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

P Melandri

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362506%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

I Zavaroni

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362506%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

1 February 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362506%20AND%20SRC:MED&resulttype=core&format=json

Journal of Endocrinological Investigation

4 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362506%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362506%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362506%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

146-152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362506%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf03345581

4 January 2020

exact match

0 references

cites work

Is liver disease a threat to patients with metabolic disorders?

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

The insulin resistance syndrome: definition and dietary approaches to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

Hepatitis C virus infection: evidence for an association with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

High prevalence of glucose abnormalities in patients with hepatitis C virus infection: a multivariate analysis considering the liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

Non-alcoholic fatty liver: another feature of the metabolicsyndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

AGA technical review on nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

Association of nonalcoholic fatty liver disease with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

Viral and host causes of fatty liver in chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

Factors associated with the presence of nonalcoholic steatohepatitis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

Updated definitions of healthy ranges for serum alanine aminotransferase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

A comparison of fibrosis progression in chronic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

Alanine aminotransferase predicts coronary heart disease events: A 10-year follow-up of the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345581

The prevalence and etiology of elevated aminotransferase levels in the United States

21 January 2018

1 reference

12 December 2020

Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study

1 reference

12 December 2020

Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease

1 reference

12 December 2020

Liver diseases and diabetes mellitus

1 reference

12 December 2020